In the latest session, Genpact Ltd (NYSE: G) closed at $32.67 down -2.59% from its previous closing price of $33.54. In other words, the price has decreased by -$0.87 from its previous closing price. On the day, 2203859 shares were traded.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Ratios:
For a deeper understanding of Genpact Ltd’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 10.12 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 13.56. For the most recent quarter (mrq), Quick Ratio is recorded 1.44 and its Current Ratio is at 1.44. In the meantime, Its Debt-to-Equity ratio is 0.67 whereas as Long-Term Debt/Eq ratio is at 0.44.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Mizuho on January 30, 2024, initiated with a Neutral rating and assigned the stock a target price of $40.
On December 15, 2023, Robert W. Baird Downgraded its rating to Neutral which previously was Outperform but kept the price unchanged to $38.
JP Morgan Downgraded its Neutral to Underweight on August 22, 2023, while the target price for the stock was maintained at $40.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Feb 15 ’24 when Klunk Donald J sold 1,845 shares for $36.27 per share. The transaction valued at 66,910 led to the insider holds 6,922 shares of the business.
White Heather sold 11,450 shares of G for $412,200 on Jan 22 ’24. The SVP & Chief Legal Officer now owns 21,175 shares after completing the transaction at $36.00 per share. On Dec 04 ’23, another insider, Stein Kathryn Vanpelt, who serves as the Senior Vice President of the company, sold 57,336 shares for $34.85 each. As a result, the insider received 1,998,149 and left with 85,775 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, G now has a Market Capitalization of 5.89B and an Enterprise Value of 6.81B. As of this moment, Genpact’s Price-to-Earnings (P/E) ratio for their current fiscal year is 9.55, and their Forward P/E ratio for the next fiscal year is 9.91. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.21. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.32 while its Price-to-Book (P/B) ratio in mrq is 2.61. Its current Enterprise Value per Revenue stands at 1.52 whereas that against EBITDA is 8.82.
Stock Price History:
Over the past 52 weeks, G has reached a high of $46.25, while it has fallen to a 52-week low of $29.41. The 50-Day Moving Average of the stock is 35.03, while the 200-Day Moving Average is calculated to be 35.75.
Shares Statistics:
For the past three months, G has traded an average of 1.41M shares per day and 1.92M over the past ten days. A total of 179.49M shares are outstanding, with a floating share count of 165.40M. Insiders hold about 8.49% of the company’s shares, while institutions hold 89.72% stake in the company. Shares short for G as of Feb 29, 2024 were 2.25M with a Short Ratio of 1.60, compared to 2.6M on Jan 31, 2024. Therefore, it implies a Short% of Shares Outstanding of 1.25% and a Short% of Float of 1.40%.
Dividends & Splits
According to the company, the forward annual dividend rate for G is 0.57, from 0.55 in the trailing year. Against a Trailing Annual Dividend Yield of 1.64%, it implies a Forward Annual Dividend Yield of 1.87%. The stock’s 5-year Average Dividend Yield is 1.04.
Earnings Estimates
There are 11 different market analysts currently analyzing its stock. On average, analysts expect EPS of $0.68 for the current quarter, with a high estimate of $0.72 and a low estimate of $0.67, while EPS last year was $0.68. The consensus estimate for the next quarter is $0.73, with high estimates of $0.74 and low estimates of $0.71.
Analysts are recommending an EPS of between $3.06 and $2.96 for the fiscal current year, implying an average EPS of $3.01. EPS for the following year is $3.3, with 12 analysts recommending between $3.47 and $3.2.
Revenue Estimates
A total of 10 analysts believe the company’s revenue will be $1.11B this quarter.It ranges from a high estimate of $1.11B to a low estimate of $1.09B. As of the current estimate, Genpact Ltd’s year-ago sales were $1.1B, an estimated increase of 1.10% from the year-ago figure. For the next quarter, 10 analysts are estimating revenue of $1.13B, an increase of 2.10% over than the figure of $1.10% in the same quarter last year. There is a high estimate of $1.13B for the next quarter, whereas the lowest estimate is $1.12B.
A total of 11 analysts have provided revenue estimates for G’s current fiscal year. The highest revenue estimate was $4.66B, while the lowest revenue estimate was $4.57B, resulting in an average revenue estimate of $4.6B. In the same quarter a year ago, actual revenue was $4.48B, up 2.70% from the average estimate. Based on 11 analysts’ estimates, the company’s revenue will be $4.88B in the next fiscal year. The high estimate is $5.05B and the low estimate is $4.81B. The average revenue growth estimate for next year is up 6.10% from the average revenue estimate for this year.
